)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Evaxion Biotech A/S (EVAX) investor relations material
Evaxion Biotech A/S Corporate Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate Presentation summary15 Oct, 2025
Strategic vision and platform
Focuses on AI-powered development of novel vaccines for cancer and infectious diseases, leveraging a clinically validated AI-Immunology™ platform for rapid and accurate target discovery and design.
Maintains a multidisciplinary capability set with advanced wetlab and animal facilities, supporting both preclinical and clinical programs.
Pursues a multi-partner approach, enabling value creation through partnerships and out-licensing, including transformative deals with major pharmaceutical companies.
Strategic ambition centers on becoming the AI partner of choice, generating positive cash flow, and driving best-in-class target discovery and validation.
Financial highlights and partnerships
Secured a $7.5 million exercise fee from MSD for the EVX-B3 program, extending cash runway to H1 2027 and potential future payments up to $592 million.
MSD partnership validates the AI-Immunology™ platform and pipeline, with MSD assuming all future development costs for EVX-B3.
MSD is the largest shareholder, holding close to 20% equity stake.
As of June 30, 2025, cash position was $14.7 million, with a market capitalization of $29.3 million.
Pipeline and clinical progress
Broad pipeline includes candidates for advanced melanoma (EVX-01, EVX-02, EVX-03), S. aureus (EVX-B1), N. gonorrhoeae (EVX-B2), Group A Streptococcus (EVX-B4), and Cytomegalovirus (EVX-V1).
EVX-01 achieved a 69% overall response rate in phase 2 for advanced melanoma, with 80% of vaccine targets inducing specific immune responses.
EVX-02 showed 100% relapse-free survival and T-cell response in adjuvant melanoma patients.
EVX-03 combines personalized neoantigens and ERV antigens, showing complete responses in mouse models and is ready for regulatory submission.
Infectious disease candidates demonstrate strong preclinical efficacy and address significant unmet needs, including antibiotic resistance.
MSD EVX-B3 deal financial and strategic impact
What is the EVX-01 2-year phase 2 efficacy readout?
AI-Immunology platform's role in new partnerships
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Evaxion Biotech A/S earnings date
Study Update22 Oct, 2025
Next Evaxion Biotech A/S earnings date
Study Update22 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Evaxion Biotech utilizes the AI platform, which is designed to reduce the identification of novel epitopes, and to develop neoantigens, vaccines, and antibody-based therapies; pNLS platform that is designed to identify novel protein structures through computational design; and 2D-to-3D structural similarity searching algorithm. It is developing EB023, a peptide based immunotherapy for the treatment of head and neck cancer. Evaxion Biotech A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage